SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-042224
Filing Date
2020-07-10
Accepted
2020-07-10 20:00:47
Documents
1
Period of Report
2020-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9684
  Complete submission text file 0001209191-20-042224.txt   11195
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVENUE E STE 200 SEATTLE WA 98101
Business Address
Cohen Chad M (Reporting) CIK: 0001524314 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38957 | Film No.: 201024128